Your browser doesn't support javascript.
loading
High-dose cytarabine (24 g/m2) in combination with idarubicin (HiDAC-3) results in high first-cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia.
Low, M; Lee, D; Coutsouvelis, J; Patil, S; Opat, S; Walker, P; Schwarer, A; Salem, H; Avery, S; Spencer, A; Wei, A.
Affiliation
  • Low M; Department of Clinical Haematology, The Alfred Hospital, Melbourne, Victoria, Australia.
Intern Med J ; 43(3): 294-7, 2013 Mar.
Article in En | MEDLINE | ID: mdl-22757980
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Gastrointestinal Tract / Induction Chemotherapy Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Intern Med J Journal subject: MEDICINA INTERNA Year: 2013 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Gastrointestinal Tract / Induction Chemotherapy Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Intern Med J Journal subject: MEDICINA INTERNA Year: 2013 Document type: Article Affiliation country: Country of publication: